Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload
选择性提高高密度脂蛋白胆固醇(HDL)水平的人类载脂蛋白AI基因疗法可对抗慢性压力超负荷小鼠的心脏肥大,减少心肌纤维化,并改善心脏功能。
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms18092012
Amin, Ruhul; Muthuramu, Ilayaraja; Aboumsallem, Joseph Pierre; Mishra, Mudit; Jacobs, Frank; De Geest, Bart